Water (Aqua), Caprylic/Capric Triglyceride, Cetearyl Ethylhexanoate, Glyceryl Stearate, Glycerin, C15-19 Alkane, Propanediol, Cetyl Alcohol, Butyrospermum Parkii (Shea) Butter, Tribehenin, Niacinamide, Beta Vulgaris (Beet) Root Extract, Fructooligosaccharides, Potassium Lactate, Sh-Polypeptide-69, Withania Somnifera Root Extract, Alanine, Arginine, Aspartic Acid, Glyceryl Linoleate, Glyceryl Linolenate, Glycine, Histidine, Hydrolyzed Collagen, Hydrolyzed Elastin, Isoleucine, Lactic Acid, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-1, PCA, Phenylalanine, Proline, Serine, Sodium Lactate, Sodium PCA, Soluble Proteoglycan, Threonine, Tocopheryl Acetate, Valine, 1,2-Hexanediol, Butylene Glycol, Caprylyl Glycol, Ethylhexylglycerin, Dimethicone, Carbomer, Ceteth-20, PEG-75 Stearate, Polysorbate 20, Steareth-20, Disodium EDTA, Phenoxyethanol, Fragrance (Parfum), Benzyl Benzoate, Beta-Caryophyllene, Camphor, Cananga Odorata Oil/Extract, Cinnamyl Alcohol, Citral, Citronellol, Citrus Aurantium Peel Oil, Citrus Limon (Lemon) Peel Oil, Geraniol, Geranyl Acetate, Hexamethylindanopyran, Juniperus Virginiana Oil, Lavandula Oil/Extract, Limonene, Linalool, Linalyl Acetate, Pinene, Terpineol, Vanillin, Caramel, Yellow 5 (CI 19140)
Therefore, oral semaglutide 14 mg was associated with incremental cost-effectiveness ratios of GBP 11,006 and 4930 per QALY gained versus empagliflozin 25 mg and sitagliptin 100 mg, respectively, and was more effective and less costly (dominant) versus liraglutide 1.8 mg
The CellTiter-Glo 2.0 Assay uses a single, ready-to-use liquid reagent that eliminates the substrate reconstitution step required with the original two-component kit
How ongoing care shapes GLP-1 outcomes 2x Longer on therapy Ongoing support keeps patients on GLP-1s 2x longer, maximizing long-term benefits 9+ Systems affected GLP-1s influence brain, heart, kidney, & more
6.5.3 Oral semaglutide in advanced T2D (mean disease duration: 1415 years) In patients with long-standing T2D and moderate renal impairment (estimated glomerular filtration rate 3059 mL/min/1.73 m 2 ) (PIONEER 5), oral semaglutide 14 mg was significantly more effective than placebo in reducing HbA 1c (ETD: 0.8%
